Altimmune to present at upcoming investor and scientific conferences

Gaithersburg, md., nov. 22, 2021 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that members of the company's management team will be presenting virtually at the following conferences:
ALT Ratings Summary
ALT Quant Ranking